Arubendol,
Asthmoprotect,
Brethaire,
Brethine,
Bricanyl,
Bricanyl SA,
Butaliret,
Butalitab,
Contimit,
KWD 2019,
KWD-2019,
KWD2019,
Monovent,
Taziken,
Tedipulmo,
Terbasmin,
Terbul,
Terbutalin AL,
Terbutalin ratiopharm,
Terbutalin Stada,
terbutalin von ct,
Terbutalin-ratiopharm,
Terbutaline,
Terbutaline Sulfate,
Terbuturmant,
Terbutaline sulfate,
23031-32-5,
TERBUTALINE HEMISULFATE,
Terbutaline hemisulfate salt,
2-t-Butylamino-1-(3,5-dihydroxyphenyl)ethanol,
DSSTox_CID_25437,
DSSTox_RID_80878,
DSSTox_GSID_45437,
2-t-Butylamino-1-[3,5-dihydroxyphenyl]ethanol,
5-(2-(tert-butylamino)-1-hydroxyethyl)benzene-1,3-diol hemisulfate,
KWD 2019,
MFCD00079584,
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol;sulfuric acid,
terbutaline-sulfate,
Brethine (TN),
Prestwick_598,
Terbutaline(sulfate),
Terbutaline (sulfate),
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol; sulfuric acid,
bis(5-(2-(tert-butylamino)-1-hydroxyethyl)benzene-1,3-diol) sulfate,
Terbutaline sulfuric acid,
AC1L9AZM,
NCGC00016772-01,
CAS-23031-32-5,
SCHEMBL26462,
CHEBI:9450,
sulfuric acid; bis(terbutaline),
CHEMBL1315867,
DTXSID3045437,
CTK8G3346,
C24H40N2O10S,
Terbutaline sulfate (JP17/USP),
HMS1569O03,
HMS2096O03,
HMS3263B13,
HMS3713O03,
BCP09034,
KS-00001F8N,
Tox21_110602,
Tox21_501126,
AKOS015909692,
Tox21_110602_1,
API0005421,
CCG-220391,
CCG-222430,
LP01126,
NCGC00016010-09,
NCGC00094394-01,
NCGC00261811-01,
EU-0101126,
FT-0674863,
V0238,
D00688,
T 2528,
031T325,
SR-01000872654,
SR-01000872654-1,
I14-31834,
F2173-0944,
Terbutaline sulfate, British Pharmacopoeia (BP) Reference Standard,
Terbutaline sulfate, European Pharmacopoeia (EP) Reference Standard,
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diolsulfuric acid,
Terbutaline sulfate, United States Pharmacopeia (USP) Reference Standard,
Bricanyl,
terbutaline,
Brethaire,
Brethine,
Terbutaline sulphate,
Terbutalin sulfate,
Bricanyl Turbuhaler,
dl-Terbutaline sulfate,
Terbutaline hemisulphate,
(+-)-Terbutaline sulfate,
(+-)-Terbutaline hemisulfate,
UNII-576PU70Y8E,
Terbutaline sulfate [USAN:JAN],
KWD-2019,
EINECS 245-386-3,
CID441334,
C12H19NO3.1/2H2O4S,
Terbutaline sulfate [USAN:USP:JAN],
ACN-052229,
CS-O-30779,
C12-H19-N-O3.1/2H2-O4-S,
1-(3,5-Dihydroxyphenyl)-2-tert-butylaminoethanol sulphate,
2-(tert-Butylamino)-1-(3 5-dihydroxyphenyl)ethanol sulfate (2:1),
Terbutaline sulfate, 98%, a beta2-adrenergic receptor agonist - 1G 1g,
(+-)-alpha-((tert-Butylamino)methyl)-3,5-dihydroxybenzyl alcohol sulfate (2:1) (salt),
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-, sulfate (2:1) (salt),
1,3-Benzenediol, 5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-, sulfate (2:1) (salt),
1,3-benzenodiol, 5-[2-[(1,1-dimetiletil)amino]-1-hidroxietil]-, sulfato (2:1),
Benzyl alcohol alpha-[(tert-butylamino)methyl]-3 5-dihydroxy-sulfate (2:1) (salt) (+-)-,
Benzyl alcohol alpha-[(tert-butylamino)methyl]-35-dihydroxy-sulfate (2:1) (salt) (8CI),
Benzyl alcohol, .alpha.-[(tert-butylamino)methyl]-3,5-dihydroxy-, sulfate (2:1) (salt),
1 3-Benzenediol 5-[2-[(1 1-dimethylethyl)amino]-1-hydroxyethyl]-(+-)-sulfate (2:1) (salt),
1,3-benzenediol, 5-[2-[(1,1-dimetiletil)] amino]-1-hidroxietil-, sulfato (2:1) (sal) (9CI),
13-Benzenediol 5-[2-[(11-dimethylethyl)amino]-1-hydroxyethyl]-sulfate (2:1) (salt) (9CI),